Download Free Sample Report

The global Non-Steroidal Anti-Inflammatory Drugs market was valued at US$ 21200 million in 2024 and is projected to reach US$ 30080 million by 2030, at a CAGR of 5.1% during the forecast period.

The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The U.S. Market is Estimated at $ Million in 2023, While China is to reach $ Million.
Non-Selective NSAIDs Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Non-Steroidal Anti-Inflammatory Drugs include Pfizer Inc., Bayer AG, GSK plc, Dr. Reddy?s Laboratories Ltd, Viatris Inc, Teva Pharmaceutical Industries Ltd., Johnson And Johnson Services, Inc. and Merck & Co., Inc., etc. in 2023, the global top five players have a share approximately % in terms of revenue.
Non-Steroidal Anti-Inflammatory Drugs are members of a therapeutic drug class which reduces pain, decreases inflammation, decreases fever,[1] and prevents blood clots. Side effects depend on the specific drug, its dose and duration of use, but largely include an increased risk of gastrointestinal ulcers and bleeds, heart attack, and kidney disease.
This report aims to provide a comprehensive presentation of the global market for Non-Steroidal Anti-Inflammatory Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-Steroidal Anti-Inflammatory Drugs. This report contains market size and forecasts of Non-Steroidal Anti-Inflammatory Drugs in global, including the following market information:
Global Non-Steroidal Anti-Inflammatory Drugs Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global top five companies in 2023 (%)
We surveyed the Non-Steroidal Anti-Inflammatory Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global Non-Steroidal Anti-Inflammatory Drugs Market, by Type, 2019-2024, 2025-2030 ($ millions)
Global Non-Steroidal Anti-Inflammatory Drugs Market Segment Percentages, by Type, 2023 (%)

• Non-Selective NSAIDs
• COX-2 Selective NSAIDs

Global Non-Steroidal Anti-Inflammatory Drugs Market, by Application, 2019-2024, 2025-2030 ($ millions)
Global Non-Steroidal Anti-Inflammatory Drugs Market Segment Percentages, by Application, 2023 (%)

• Dental Pain
• Muscle Aches
• Pain caused by Gout
• Bursitis
• Menstrual Cramps
• Fever
• Others

Global Non-Steroidal Anti-Inflammatory Drugs Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions)
Global Non-Steroidal Anti-Inflammatory Drugs Market Segment Percentages, By Region and Country, 2023 (%)

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
• The Middle East and Africa (Middle East, Africa)
• South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Non-Steroidal Anti-Inflammatory Drugs revenues in global market, 2019-2024 (estimated), ($ millions)
• Key companies Non-Steroidal Anti-Inflammatory Drugs revenues share in global market, 2023 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer Inc.
• Bayer AG
• GSK plc
• Dr. Reddy?s Laboratories Ltd
• Viatris Inc
• Teva Pharmaceutical Industries Ltd.
• Johnson And Johnson Services, Inc.
• Merck & Co., Inc.
• Including or Excluding key companies relevant to your analysis.

Outline of Major Chapters:
Chapter 1: Introduces the definition of Non-Steroidal Anti-Inflammatory Drugs, market overview.
Chapter 2: Global Non-Steroidal Anti-Inflammatory Drugs market size in revenue.
Chapter 3: Detailed analysis of Non-Steroidal Anti-Inflammatory Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Non-Steroidal Anti-Inflammatory Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.